Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on Insulin Sensitivity and Glycaemic Control

Clinical trial NCT04529473 · COMPLETED

Trial details

NCT number: NCT04529473
Sponsor: Atlantia Food Clinical Trials
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pre Diabetes Impaired Glucose Tolerance Insulin Sensitivity Insulin Resistance Glucose Metabolism Disorders Metabolic Syndrome

Start date: 2021-02-03
Primary completion: 2022-08-23
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.